Brokerages Set Waldencast PLC (NASDAQ:WALD) Price Target at $4.42

Shares of Waldencast PLC (NASDAQ:WALD) have received an average rating of “Moderate Buy” from the six research firms that are covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and four have given a buy rating to the company. The average 1-year target price among brokers that have issued ratings on the stock in the last year is $4.4167.

WALD has been the subject of a number of recent research reports. Canaccord Genuity Group decreased their price target on shares of Waldencast from $5.00 to $4.00 and set a “buy” rating for the company in a research note on Tuesday, November 25th. Jefferies Financial Group assumed coverage on shares of Waldencast in a report on Wednesday, January 14th. They issued a “buy” rating and a $2.00 price objective on the stock. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Waldencast in a research report on Wednesday, January 21st. Finally, Telsey Advisory Group downgraded shares of Waldencast from an “outperform” rating to a “market perform” rating and set a $3.00 target price for the company. in a research note on Tuesday, November 25th.

Waldencast Trading Up 8.2%

WALD stock opened at $1.58 on Friday. The business’s 50-day moving average is $1.68 and its two-hundred day moving average is $1.87. The company has a quick ratio of 0.67, a current ratio of 1.53 and a debt-to-equity ratio of 0.32. Waldencast has a 1 year low of $1.41 and a 1 year high of $3.51.

Waldencast (NASDAQ:WALD) last announced its quarterly earnings data on Monday, November 24th. The company reported ($0.69) EPS for the quarter. The firm had revenue of $66.14 million during the quarter. On average, equities research analysts anticipate that Waldencast will post -0.14 EPS for the current fiscal year.

Institutional Trading of Waldencast

A number of institutional investors have recently bought and sold shares of WALD. Milestones Administradora de Recursos Ltda. boosted its position in shares of Waldencast by 10.3% during the 3rd quarter. Milestones Administradora de Recursos Ltda. now owns 2,425,677 shares of the company’s stock worth $4,803,000 after acquiring an additional 225,677 shares in the last quarter. Stoic Point Capital Management LLC acquired a new stake in shares of Waldencast during the 4th quarter worth about $2,628,000. UBS Group AG lifted its stake in Waldencast by 466.2% during the third quarter. UBS Group AG now owns 838,536 shares of the company’s stock worth $1,660,000 after purchasing an additional 690,441 shares during the last quarter. Geode Capital Management LLC lifted its stake in Waldencast by 62.2% during the second quarter. Geode Capital Management LLC now owns 586,566 shares of the company’s stock worth $1,437,000 after purchasing an additional 224,905 shares during the last quarter. Finally, Beartown Capital Management LLC acquired a new position in Waldencast in the fourth quarter valued at approximately $564,000. 41.97% of the stock is owned by hedge funds and other institutional investors.

Waldencast Company Profile

Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians. The company also offers clean makeup products under the Milk Makeup brand. It sells its products to dermatologists, plastic surgeons, and other physicians who focuses on aesthetic and therapeutic skincare, including physicians on site at medical spas, through its direct sales force, as well as through distribution partners.